Robert Connelly is the founder of Elicio Therapeutics. Elicio Therapeutics has raised $163M in total funding. Latest round: IPO. Backed by BridgeGap Ventures.
Robert Connelly joined Elicio Therapeutics as CEO in October 2018. He has 40 years of leadership experience in the Life Sciences sector, including 25 years as a chief executive officer. He has founded and led numerous startup and early-stage therapeutic companies.
Full founder directory · Investor directory · Company funding database · Fundraising library